These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15268822)

  • 1. [Classification and diagnostic strategies of drug-induced hepatic disease].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):445-6. PubMed ID: 15268822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of 93 cases of drug induced hepatitis].
    Lu MH; Yang YX; Tan DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):608-9. PubMed ID: 16137063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatotoxicity of antituberculosis drugs: practical implications for monitoring].
    Durand F; Bernuau J; Pessayre D
    Gastroenterol Clin Biol; 1998 Feb; 22(2):117-20. PubMed ID: 9762183
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients.
    Zhou Y; Yang L; Liao Z; He X; Zhou Y; Guo H
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):825-9. PubMed ID: 23510965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognostic analysis of 51 drug-induced case of liver failure].
    He WP; Liu XY; Hu JH; Wang HF
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(7):482-5. PubMed ID: 20368074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities of influencing the hepatotoxicity of chemotherapeutics by the use of silymarin].
    Barton P; Krejcí V; Blazek M
    Cas Lek Cesk; 1985 Feb; 124(6):173-5. PubMed ID: 3971405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chinese herbal medicine induced liver injury].
    Gao XD; Fan YH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):478-80. PubMed ID: 19567037
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced hepatic injury.
    Farrell GC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S242-50. PubMed ID: 9407344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Centrilobular liver necrosis following antimycobacterial treatment].
    Beckert W
    Z Erkr Atmungsorgane Folia Bronchol; 1971 Aug; 135(1):11-7. PubMed ID: 5209484
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
    Ijaz K; McElroy PD; Navin TR
    Clin Infect Dis; 2004 Jul; 39(2):289. PubMed ID: 15307044
    [No Abstract]   [Full Text] [Related]  

  • 11. Antituberculosis drugs and hepatotoxicity.
    Yew WW; Leung CC
    Am J Respir Crit Care Med; 2007 Apr; 175(8):858; author reply 858-9. PubMed ID: 17405943
    [No Abstract]   [Full Text] [Related]  

  • 12. Herbal hepatotoxicity: an expanding but poorly defined problem.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1093-9. PubMed ID: 11106086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of polyunsaturated phosphatidylcholine associated with a vitamin B complex in the treatment of hepatic injuries caused by antitubercular agents].
    Lazzara A; Maucceri G; Costanzo V; Granata M
    Clin Ter; 1986 Sep; 118(6):423-6. PubMed ID: 3780172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatic function and antitubercular drugs].
    Fossati C
    Clin Ter; 1978 Sep; 86(5):495-501. PubMed ID: 367684
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe hepatic injury and adulterated Chinese medicines.
    Lai V; Smith A; Thorburn D; Raman VS
    BMJ; 2006 Feb; 332(7536):304-5. PubMed ID: 16455741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-induced liver diseases].
    Bode JC
    Dtsch Med Wochenschr; 1985 Oct; 110(40):1543-8. PubMed ID: 3899567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-tubercular agent injuries to the liver in liver disease].
    Zhang P
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):643-4. PubMed ID: 11477886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chinese herb and drug-induced liver injury].
    Hu YY; Huang F
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):173-5. PubMed ID: 22629577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.